Cargando…
LAIR1 drives glioma progression by nuclear focal adhesion kinase dependent expressions of cyclin D1 and immunosuppressive chemokines/cytokines
Leukocyte-associated immunoglobulin-like receptor-1 (LAIR1), an immune receptor containing immunoreceptor tyrosine-based inhibiory motifs (ITIMs), has emerged as an attractive target for cancer therapy. However, the intrinsic function of LAIR1 in gliomas remains unclear. In this study, the poor prog...
Autores principales: | Wei, Xiaoqian, Pan, Shushan, Wang, Zirui, Chen, Jieru, Lu, Li, Cao, Qizhi, Song, Shuling, Zhang, Huachang, Liu, Xiaohui, Qu, Xianjun, Lin, Xiukun, Xu, Huanli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579300/ https://www.ncbi.nlm.nih.gov/pubmed/37845206 http://dx.doi.org/10.1038/s41419-023-06199-9 |
Ejemplares similares
-
LAIR-1 Limits Neutrophilic Airway Inflammation
por: Kumawat, Kuldeep, et al.
Publicado: (2019) -
Gargamelle's new lair
Publicado: (1975) -
L'air comprimé
por: Lefèvre, Jean
Publicado: (1951) -
Cyclin G2 reverses immunosuppressive tumor microenvironment and potentiates PD-1 blockade in glioma
por: Li, Sen, et al.
Publicado: (2021) -
Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression
por: Son, Myoungsun, et al.
Publicado: (2017)